Two investigational antitumor agents work better together against MPNST and neuroblastoma

A new study demonstrates that the combined usage of Aurora A kinase inhibitor (alisertib) and HSV1716 results in significantly increased antitumor efficacy in models of malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma.
Source: ScienceDaily Headlines - Category: Science Source Type: news